Latest News for: her3

Edit

Akeso's Next-Generation HER3 ADC AK138D1 Combined with Ivonescimab: First Patient Enrolled in Phase Ib/II Breast Cancer Study, Advancing the IO2.0 + ADC2.0 Strategy

PR Newswire 15 Jun 2026
HER3 is broadly expressed across various solid tumors, including breast, ovarian, colon, gastric, lung, skin, and pancreatic cancers, affecting millions of patients globally ... After binding to HER3 on ...
Edit

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ...

Killeen Daily Herald 21 Apr 2026
SHANGHAI, April 20, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX. 1877; ....
Edit

CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)

Lincoln Times-News 20 Apr 2026
SUZHOU, China, April 19, 2026 /PRNewswire/ -- CStone ...
  • 1

Article Search

tools
×
×
×
×